Description

Product details

INH AIRFLOW MAX F250 combines two trusted respiratory agents — Formoterol (6 mcg) and Fluticasone (250 mcg) — in one convenient inhaler. This dual-therapy formulation is designed to deliver both rapid bronchodilation and long-term anti-inflammatory control, helping patients manage asthma and chronic obstructive pulmonary disease (COPD) more effectively. Manufactured by Steris Healthcare Pvt. Ltd., INH AIRFLOW MAX F250 ensures reliable performance, quality assurance, and enhanced patient compliance. Key Indications INH AIRFLOW MAX F250 is indicated for: Asthma Maintenance Therapy: Provides long-term control of moderate to severe asthma. Symptom Relief: Reduces shortness of breath, wheezing, chest tightness, and airway inflammation. COPD Management: Controls chronic respiratory symptoms and reduces the frequency and severity of COPD exacerbations. Mechanism of Action INH AIRFLOW MAX F250 works through two complementary mechanisms: 1. Formoterol (6 mcg) — Long-Acting Beta Agonist (LABA) Action: Relaxes airway smooth muscles for rapid and sustained bronchodilation. Benefit: Provides relief within minutes and lasts up to 12 hours. 2. Fluticasone (250 mcg) — Corticosteroid Action: Reduces airway inflammation and prevents swelling of the bronchial walls. Benefit: Improves long-term respiratory control and reduces the risk of asthma attacks. Together, these agents ensure both immediate symptom relief and prolonged protection against respiratory flare-ups. Dosage and Administration Recommended Dose: As prescribed by a physician — usually one or two inhalations twice daily. Route: Oral inhalation only. Timing: Use at the same time each day for best results. Technique: Shake well before use and rinse mouth after each use to prevent throat irritation or infection. ⚠️ Always follow your doctor’s instructions. Do not self-adjust or discontinue the medicine without consultation. Key Benefits of INH AIRFLOW MAX F250 Provides dual-action relief — rapid bronchodilation + anti-inflammatory control. Ensures better breathing comfort and reduced daily symptoms. Prevents asthma and COPD exacerbations, improving long-term lung function. Convenient single-inhaler therapy improves adherence and treatment consistency. Suitable for chronic use under medical supervision. Possible Side Effects Common Side Effects: Throat irritation or hoarseness Mild headache Tremor or shakiness Nausea or cough Serious but Rare Side Effects: Respiratory infections (e.g., pneumonia) Allergic reactions (rash, swelling, or difficulty breathing) Reduced bone density with long-term steroid use Rinse your mouth after each inhalation to lower the risk of oral thrush or irritation. Safety and Precautions Inform your physician about any heart, liver, or thyroid conditions before starting therapy. Not recommended during pregnancy or breastfeeding unless medically advised. Avoid exposure to tobacco smoke or environmental irritants. Regular lung function monitoring is recommended for long-term users. Storage Instructions Store below 30 °C, in a cool, dry place away from direct sunlight. Keep the inhaler tightly closed and out of reach of children. Do not use after the expiry date printed on the label. Why Choose INH AIRFLOW MAX F250 Developed by Steris Healthcare Pvt. Ltd., a trusted leader in respiratory care. Combines proven molecules for optimized asthma and COPD management. Ensures consistent dosing accuracy and ease of use. Backed by clinical reliability and patient-focused innovation.

Other Specifications